IL1B and breast carcinoma: Claudia Tulotta and other researchers discovered that tumor-derived IL-1β limited primary tumor development, reestablished the infiltration of immune cells with potential antitumor functions, and supported breast cancer metastasis, by enhancing the motility and inhibiting the proliferation of tumor cells [92].